Plasma Metabolomic Profiles in Recovered COVID-19 Patients without Previous Underlying Diseases 3 Months After Discharge

References

• WHO. Coronavirus disease (COVID-19) dashboard; 2021. Available from: https://covid19.who.int. Accessed August 16, 2021.
   Google Scholar
• Fang Y, Zhou J, Ding X, Ling G, Yu S. Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: preliminary experience. Am J Emerg Med. 2020;38(10):2134–2138. doi:10.1016/j.ajem.2020.05.120
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. doi:10.1001/jamacardio.2020.3557
   PubMed Web of Science ®Google Scholar
• Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330–2339. doi:10.1016/j.jcmg.2020.05.004
   PubMed Web of Science ®Google Scholar
• Li J, Long X, Zhu C, et al. Olfactory dysfunction in recovered Coronavirus Disease 2019 (COVID-19) patients. Mov Disord. 2020;35(7):1100–1101. doi:10.1002/mds.28172
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhou L, Sun X, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110. doi:10.1038/s41598-017-09536-z
   PubMed Web of Science ®Google Scholar
• Banoei MM, Vogel HJ, Weljie AM, et al. Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia. Critical Care. 2017;21(1):97. doi:10.1186/s13054-017-1672-7
   PubMedGoogle Scholar
• Fujiogi M, Camargo CA Jr, Raita Y, et al. Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: a multicenter study. Pediatr Allergy Immunol. 2020;31(7):755–766. doi:10.1111/pai.13296
   PubMed Web of Science ®Google Scholar
• Eisfeld AJ, Halfmann PJ, Wendler JP, et al. Multi-platform ‘omics analysis of human Ebola virus disease pathogenesis. Cell Host Microbe. 2017;22(6):817–829.e818. doi:10.1016/j.chom.2017.10.011
   PubMed Web of Science ®Google Scholar
• Cui L, Pang J, Lee YH, et al. Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection. PLoS Negl Trop Dis. 2018;12(1):e0006217. doi:10.1371/journal.pntd.0006217
   PubMed Web of Science ®Google Scholar
• Song JW, Lam SM, Fan X, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32(2):188–202.e185. doi:10.1016/j.cmet.2020.06.016
   PubMed Web of Science ®Google Scholar
• Wu D, Shu T, Yang X, et al. Plasma metabolomic and lipidomic alterations associated with COVID-19. Nat Sci Rev. 2020;7:7. doi:10.1093/nsr/nwaa086
   PubMed Web of Science ®Google Scholar
• Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59–72.e15. doi:10.1016/j.cell.2020.05.032
   PubMed Web of Science ®Google Scholar
• Shi D, Yan R, Lv L, et al. The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism. 2021;118:154739. doi:10.1016/j.metabol.2021.154739
   PubMed Web of Science ®Google Scholar
• Marín-Corral J, Rodríguez-Morató J, Gomez-Gomez A, et al. Metabolic signatures associated with severity in hospitalized COVID-19 patients. Int J Mol Sci. 2021;22(9):4794. doi:10.3390/ijms22094794
   PubMed Web of Science ®Google Scholar
• Danlos FX, Grajeda-Iglesias C, Durand S, et al. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021;12(3):258. doi:10.1038/s41419-021-03540-y
   PubMed Web of Science ®Google Scholar
• Barberis E, Timo S, Amede E, et al. Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int J Mol Sci. 2020;21(22):8623. doi:10.3390/ijms21228623
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao M, Li C, Zhang Y, Wang DW. The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage. Biosci Rep. 2021;41(3):BSR20204201. doi:10.1042/BSR20204201
   PubMedGoogle Scholar
• Acosta-Ampudia Y, Monsalve DM, Rojas M, et al. COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun. 2021;118:102598. doi:10.1016/j.jaut.2021.102598
   PubMed Web of Science ®Google Scholar
• Xu J, Zhou M, Luo P, et al. Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge. Clin Infect Dis. 2021:ciab147. doi:10.1093/cid/ciab147
   Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722. doi:10.1148/radiol.2462070712
   PubMed Web of Science ®Google Scholar
• Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang Q, Huang C, et al. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020;10(12):5613–5622. doi:10.7150/thno.45985
   PubMed Web of Science ®Google Scholar
• Smilde AK, van der Werf MJ, Bijlsma S, van der Werff-van der Vat BJC, Jellema RH. Fusion of mass spectrometry-based metabolomics data. Anal Chem. 2005;77(20):6729–6736. doi:10.1021/ac051080y
   PubMed Web of Science ®Google Scholar
• Kamleh MA, Ebbels TM, Spagou K, Masson P, Want EJ. Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies. Anal Chem. 2012;84(6):2670–2677. doi:10.1021/ac202733q
   PubMed Web of Science ®Google Scholar
• Luo P, Yin P, Zhang W, et al. Optimization of large-scale pseudotargeted metabolomics method based on liquid chromatography-mass spectrometry. J Chromatogr A. 2016;1437:127–136. doi:10.1016/j.chroma.2016.01.078
   PubMed Web of Science ®Google Scholar
• Luo P, Yin P, Hua R, et al. A large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2018;67(2):662–675. doi:10.1002/hep.29561
   PubMed Web of Science ®Google Scholar
• Luo P, Mao K, Xu J, et al. Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy. J Extracell Vesicles. 2020;9(1):1790158. doi:10.1080/20013078.2020.1790158
   PubMed Web of Science ®Google Scholar
• Ayres JS. A metabolic handbook for the COVID-19 pandemic. Nat Metab. 2020;2(7):572–585. doi:10.1038/s42255-020-0237-2
   PubMedGoogle Scholar
• Maddocks OD, Berkers CR, Mason SM, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2013;493(7433):542–546. doi:10.1038/nature11743
   PubMed Web of Science ®Google Scholar
• Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200–1204. doi:10.1038/s41591-020-0965-6
   PubMed Web of Science ®Google Scholar
• Gu S, Chen Y, Wu Z, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. 2020;71(10):2669–2678. doi:10.1093/cid/ciaa709
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu Q, Zhang F, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70(2):276–284.
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22–39. doi:10.1080/19490976.2015.1127483
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005
   PubMed Web of Science ®Google Scholar
• Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678–693. doi:10.1038/nrd2619
   PubMed Web of Science ®Google Scholar
• Pai AB, Patel H, Prokopienko AJ, et al. Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species. PLoS One. 2012;7(11):e49209. doi:10.1371/journal.pone.0049209
   PubMed Web of Science ®Google Scholar
• Lai YL, Chiou WY, Lu FJ, Chiang LY. Roles of oxygen radicals and elastase in citric acid-induced airway constriction of guinea-pigs. Br J Pharmacol. 1999;126(3):778–784. doi:10.1038/sj.bjp.0702352
   PubMed Web of Science ®Google Scholar
• Chen YF, Huang G, Wang YM, et al. Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice. Respir Res. 2019;20(1):285. doi:10.1186/s12931-019-1260-2
   PubMed Web of Science ®Google Scholar
• Wang M, Guo X, Zhao H, Lv J, Wang H, An Y. Adenosine A(2B) receptor activation stimulates alveolar fluid clearance through alveolar epithelial sodium channel via cAMP pathway in endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2020;318(4):L787–Ll800. doi:10.1152/ajplung.00195.2019
   PubMed Web of Science ®Google Scholar
• Xicoy H, Wieringa B, Martens GJM. The role of lipids in parkinson’s disease. Cells. 2019;8(1):27. doi:10.3390/cells8010027
   PubMed Web of Science ®Google Scholar
• Cheng ML, Wang CH, Shiao MS, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015;65(15):1509–1520. doi:10.1016/j.jacc.2015.02.018
   PubMed Web of Science ®Google Scholar
• Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol. 2013;45(6):1121–1132. doi:10.1016/j.biocel.2013.02.019
   PubMed Web of Science ®Google Scholar
• Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339–1348. doi:10.1007/s00134-020-06153-9
   PubMed Web of Science ®Google Scholar
• Hallan S, Afkarian M, Zelnick LR, et al. Metabolomics and gene expression analysis reveal down-regulation of the Citric Acid (TCA) cycle in non-diabetic CKD patients. EBioMedicine. 2017;26:68–77. doi:10.1016/j.ebiom.2017.10.027
   PubMed Web of Science ®Google Scholar
• Tan SM, Ziemann M, Thallas-Bonke V, et al. Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes. 2020;69(1):83–98. doi:10.2337/db19-0043
   PubMed Web of Science ®Google Scholar
• Duranton F, Cohen G, De Smet R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012;23(7):1258–1270. doi:10.1681/ASN.2011121175
   PubMed Web of Science ®Google Scholar
• Jakaria M, Azam S, Haque ME, et al. Taurine and its analogs in neurological disorders: focus on therapeutic potential and molecular mechanisms. Redox Biol. 2019;24:101223. doi:10.1016/j.redox.2019.101223
   PubMed Web of Science ®Google Scholar
• Sun Q, Wang B, Li Y, et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: randomized, Double-Blind, Placebo-Controlled Study. Hypertension. 2016;67(3):541–549. doi:10.1161/HYPERTENSIONAHA.115.06624
   PubMed Web of Science ®Google Scholar
• Murakami S, Sakurai T, Toda Y, Morito A, Sakono M, Fukuda N. Prevention of neointima formation by taurine ingestion after carotid balloon injury. Vascul Pharmacol. 2010;53(3–4):177–184. doi:10.1016/j.vph.2010.07.003
   PubMed Web of Science ®Google Scholar
• Zulli A, Lau E, Wijaya BP, et al. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension. 2009;53(6):1017–1022. doi:10.1161/HYPERTENSIONAHA.109.129924
   PubMed Web of Science ®Google Scholar
• Ito T, Kimura Y, Uozumi Y, et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol. 2008;44(5):927–937. doi:10.1016/j.yjmcc.2008.03.001
   PubMed Web of Science ®Google Scholar
• L’Amoreaux WJ, Cuttitta C, Santora A, Blaize JF, Tachjadi J, El Idrissi A. Taurine regulates insulin release from pancreatic beta cell lines. J Biomed Sci. 2010;17 Suppl 1(Suppl1):S11. doi:10.1186/1423-0127-17-S1-S11
   PubMedGoogle Scholar
• Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463–469. doi:10.1038/s41586-020-2588-y
   PubMed Web of Science ®Google Scholar
• Zeisel SH. Choline: an essential nutrient for humans. Nutrition. 2000;16(7–8):669–671. doi:10.1016/S0899-9007(00)00349-X
   PubMed Web of Science ®Google Scholar
• Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr. 1994;14:269–296. doi:10.1146/annurev.nu.14.070194.001413
   PubMed Web of Science ®Google Scholar
• Roe AJ, Zhang S, Bhadelia RA, et al. Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults. Am J Clin Nutr. 2017;105(6):1283–1290.
   PubMed Web of Science ®Google Scholar
• Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639–648. doi:10.2337/db12-0495
   PubMed Web of Science ®Google Scholar